2型糖尿病成人8年多病共存与衰弱变化及其与认知、躯体功能和死亡的关系
研究基于3 842名45-76岁超重/肥胖的2型糖尿病成人,分析8年间多病共存指数和衰弱指数(FI)变化与随后10年认知、躯体功能及死亡的关系。结果显示,多病共存和衰弱指数增加均与复合认知功能更差、400米步行速度更慢及死亡风险增加相关。
要点
- 多病共存与衰弱指数变化呈中度相关(r=0.26;p<.001)。
- 8年间多病共存或衰弱指数增加者,后续认知与躯体功能更差、死亡风险更高。
- 强化生活方式干预能否降低上述下游风险尚待验证。
核心结论
- 以多病共存和衰弱指数反映的加速生物学衰老可预测随后功能下降和死亡。
研究设计与样本
- 基于Action for Health in Diabetes临床试验3 842名参与者,基线45-76岁,因超重/肥胖和2型糖尿病处于加速生物学衰老风险中。
- 分析8年间多病共存指数(9种慢性病)和衰弱指数(功能、行为、临床特征缺陷累积)变化与随后10年认知和躯体功能指标及死亡的关联。
主要发现
- 1 501名(39%)参与者在9种疾病追踪中8年间多病共存增加1种,868名(23%)增加≥2种。
- 多病共存增加最多者倾向为年龄较大、男性、非西班牙裔白人。
- 衰弱指数增加较多者倾向为年龄较大、非西班牙裔白人、体重较重、基线疾病更多。
- 多病共存与衰弱指数变化呈中度相关(r=0.26;p<.001)。
- 多病共存与衰弱指数增加均与随后复合认知功能更差、400米步行速度更慢及死亡风险增加相关(均p<.001)。
关键数值与推荐
- 多病共存指数:9种慢性病,8年间增加1种者1 501人(39%),增加≥2种者868人(23%)。
- 衰弱指数:基于功能、行为和临床特征缺陷累积。
- 多病共存与衰弱指数变化相关系数r=0.26;p<.001。
- 多病共存和衰弱指数增加与认知、400米步行速度及死亡结局关联均p<.001。
临床怎么用
- 对超重/肥胖的2型糖尿病中老年人,可动态评估多病共存和衰弱指数变化以识别功能下降和死亡高风险者。
- 多病共存与衰弱指数变化仅中度相关,提示两者可互补用于风险分层。
局限性
- 研究对象为超重/肥胖的2型糖尿病临床试验人群,结果外推需谨慎。
- 强化生活方式干预能否降低下游风险尚待研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indices of multimorbidity and deficit accumulation (ie, frailty indices) have been proposed as markers of biological aging. If true, changes in these indices over time should predict downstream changes in cognition and physical function, and mortality. METHODS: We examined associations that 8-year changes in (i) a multimorbidity index comprised of 9 chronic diseases and (ii) a frailty index (FI) based on deficit accumulation in functional, behavioral, and clinical characteristics had with subsequent measures of cognitive and physical function over 10 years. We drew data from 3 842 participants in the Action for Health in Diabetes clinical trial. They were aged 45-76 years at baseline and at risk for accelerated biological aging due to overweight/obesity and type 2 diabetes mellitus. RESULTS: A total of 1 501 (39%) of the cohort had 8-year increases of 1 among the 9 diseases tracked in the multimorbidity index and 868 (23%) had increases of ≥2. Those with greatest increases in multimorbidity tended to be older individuals, males, and non-Hispanic Whites. Greater FI increases tended to occur among individuals who were older, non-Hispanic White, heavier, and who had more baseline morbidities. Changes in multimorbidity and FI were moderately correlated (r = 0.26; p < .001). Increases in both multimorbidity and FI were associated with subsequently poorer composite cognitive function and 400-m walk speed and increased risk for death (all p < .001). CONCLUSIONS: Accelerated biological aging, as captured by multimorbidity and frailty indices, predicts subsequent reduced function and mortality. Whether intensive lifestyle interventions generally targeting multimorbidity and FI reduce risks for downstream outcomes remains to be seen. Clinical Trials Registration Number: NCT00017953.
引用
- Espeland MA, Justice JN, Bahnson J, et al. Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34788804. doi:10.1093/gerona/glab342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。